Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment
<b>Background:</b> Cenobamate is a novel antiseizure medication with potential interactions involving cytochrome P450 enzymes, including CYP2C19. Genetic variability in CYP2C19 may influence drug metabolism and tolerability, although its clinical relevance in cenobamate-treated patients remains uncl...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2026-06-01
|
| シリーズ: | Applied Sciences |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2076-3417/16/11/5679 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|